NCT03667053 - Trial to Confirm the Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in T1DM Children | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 28, 2018

Primary Completion Date

June 28, 2019

Study Completion Date

June 28, 2019

Conditions

Hypoglycemia

Interventions

DRUG

dasiglucagon

glucagon analog

DRUG

placebo

placebo for dasiglucagon

DRUG

GlucaGen HypoKit

native glucagon

Trial Locations (5)

University Medical Center Ljubljana, Children's Hospital, Department for Endocrinology, Diabetes and Metabolism, Ljubljana

Auf der Bult - Diabetes Center for Children, Hanover

Indiana University, Department of Pediatrics, Indianapolis

AMCR Institute, Inc, Escondido

Yale University School of Medicine, New Haven